Bioresorbable Polymers Market Analysis and Forecast to 2031: By Type(Polylactic Acid (PLA), Polyglycolic Acid (PGA), Polylactic-co-glycolic acid (PLGA), Polycaprolactone (PCL)), Application (Orthopedic Devices, Drug Delivery), and Region
Bioresorbable polymers are polymers that are broken down by the body. The body’s cells can recognize and break down these polymers, which makes them ideal for use in medical devices. Bioresorbable polymers are made from natural or synthetic materials, and they are slowly broken down by the body over time. This process is called bioresorption.
Key Trends
There are several key trends in the field of bioresorbable polymers.
Firstly, there is a trend towards the development of more biocompatible materials. This means that the materials are less likely to cause an immune reaction or other negative side effects when used in the body.
Additionally, there is a trend towards the development of materials that can be broken down by the body more easily. This is important because it reduces the risk of the material being rejected by the body or causing other complications.
Finally, there is a trend towards the development of materials that can be used for a variety of different medical applications. This means that the materials can be used for a wide range of different procedures, including surgery, wound healing, and drug delivery.
Key Drivers
The key drivers of the bioresorbable polymers market are the increasing preference for minimally invasive surgeries, the growing demand for these polymers in orthopedic applications, and the rising awareness about the benefits of these polymers.
Minimally invasive surgeries are associated with reduced surgical trauma, blood loss, and postoperative pain, which is fuelling the demand for these polymers.
The orthopedic applications of bioresorbable polymers are growing owing to the increasing incidence of sports injuries and the growing aging population.
The rising awareness about the benefits of these polymers, such as the ability to promote tissue regeneration, is also fuelling the market growth.
Restraints & Challenges
The key restraints and challenges in Bioresorbable Polymers market include the lack of awareness about the benefits of these polymers, stringent regulations, and the high cost of these polymers.
Lack of awareness about the benefits of bioresorbable polymers: Bioresorbable polymers are a relatively new technology and many people are not aware of their existence or how they can be used. This lack of awareness is a major barrier to the adoption of these polymers.
Stringent regulations: There are currently no regulations specifically governing the use of bioresorbable polymers. This lack of regulation can make it difficult for companies to develop and market products made with these polymers.
High cost: Bioresorbable polymers are typically more expensive than traditional plastics. This high cost can make it difficult for companies to justify the use of these polymers in their products.
Market Segments
The Bioresorbable Polymers Market is segmented by type, application, and region. By type, the market is divided into polylactic acid (PLA), polyglycolic acid (PGA), polylactic-co-glycolic acid (PLGA), and polycaprolactone (PCL). Based on application, it is bifurcated into orthopedic devices, drug delivery, and others. Region-wise, the market is divided into North America, Europe, Asia-Pacific, and the Rest of the World.
Key Players
The Bioresorbable Polymers Market includes players such as Corbion N.V., Evonik Industries AG, Foster Corporation, KLS Martin Group, DSM Biomedical, Inc., Ashland Global Holdings Inc., Zeus Industrial Products, Inc., Seqens Group, REVA Medical, LLC and Poly-Med Incorporated.
Table of Contents
Chapter 1. Market Introduction
1.1. Objectives of the Study
1.2. Market Definition and Research & Scope
1.3. Research Methodologies
1.4. Market Estimation Techniques
Chapter 2. Executive Summary
2.1. Summary
2.2. Key Highlights of the Market
Chapter 3. Bioresorbable Polymers Market Outlook
3.1. Bioresorbable Polymers Market segmentation
3.2. Market Dynamics
3.2.1. Market Drivers
3.2.1.1. Driver 1
3.2.1.2. Driver 2
3.2.1.3. Driver 3
3.2.2. Market Restraints
3.2.2.1. Restraint 1
3.2.2.2. Restraint 2
3.2.3. Market Opportunities
3.2.3.1. Opportunity 1
3.2.3.2. Opportunity 2
3.3. Porter’s Five Forces Analysis
3.3.1. Threat of New Entrants
3.3.2. Threat of Substitutes
3.3.3. Bargaining Power of Buyers
3.3.4. Bargaining Power of Supplier
3.3.5. Competitive Rivalry
3.4. PESTLE Analysis
3.5. Value Chain Analysis
3.5.1. Raw Material Suppliers
3.5.2. Manufacturers
3.5.3. Wholesalers and/or Retailers
3.6. Impact of the Russia and Ukraine War on the Bioresorbable Polymers Market
Chapter 4. Economic Impact of COVID-19 on Bioresorbable Polymers Market
4.1. Overall Impact of COVID-19
4.2. Impact of COVID On the Bioresorbable Polymers Market
4.3. Economic Impact Analysis
Chapter 5. Bioresorbable Polymers Market by Type
5.1. Market Overview
5.2. Polylactic acid (PLA)
5.2.1. Market Size and Forecast, 2021-2031 ($Million)
5.2.2. Market Size and Forecast, by Region, 2021-2031 ($Million)
5.3. Polyglycolic acid (PGA)
5.3.1. Market Size and Forecast, 2021-2031 ($Million)
5.3.2. Market Size and Forecast, by Region, 2021-2031 ($Million)
5.4. Polylactic-co-glycolic acid (PLGA)
5.4.1. Market Size and Forecast, 2021-2031 ($Million)
5.4.2. Market Size and Forecast, by Region, 2021-2031 ($Million)
5.5. Polycaprolactone(PCL)
5.5.1. Market Size and Forecast, 2021-2031 ($Million)
5.5.2. Market Size and Forecast, by Region, 2021-2031 ($Million)
Chapter 6. Bioresorbable Polymers Market by Application
6.1. Market Overview
6.2. Orthopedic devices
6.2.1. Market Size and Forecast, 2021-2031 ($Million)
6.2.2. Market Size and Forecast, by Region, 2021-2031 ($Million)
6.3. Drug delivery
6.3.1. Market Size and Forecast, 2021-2031 ($Million)
6.3.2. Market Size and Forecast, by Region, 2021-2031 ($Million)
6.4. Others
6.4.1. Market Size and Forecast, 2021-2031 ($Million)
6.4.2. Market Size and Forecast, by Region, 2021-2031 ($Million)
Chapter 7. Bioresorbable Polymers Market, by Region
7.1. Overview
7.2. North America
7.2.1. Key Market Trends and Opportunities
7.2.2. North America Bioresorbable Polymers Market Size and Forecast by Type, 2021-2031, ($Million)
7.2.3. North America Bioresorbable Polymers Market Size and Forecast by Application, 2021-2031, ($Million)
7.2.4. North America Bioresorbable Polymers Market Size and Forecast by Country, 2021-2031, ($Million)
7.2.5. The U.S.
7.2.5.1. The U.S. Bioresorbable Polymers Market Size and Forecast by Type, 2021-2031, ($Million)
7.2.5.2. The U.S. Bioresorbable Polymers Market Size and Forecast by Application, 2021-2031, ($Million)
7.2.6. Canada
7.2.6.1. Canada Bioresorbable Polymers Market Size and Forecast by Type, 2021-2031, ($Million)
7.2.6.2. Canada Bioresorbable Polymers Market Size and Forecast by Application, 2021-2031, ($Million)
7.2.7. Mexico
7.2.7.1. Mexico Bioresorbable Polymers Market Size and Forecast by Type, 2021-2031, ($Million)
7.2.7.2. Mexico Bioresorbable Polymers Market Size and Forecast by Application, 2021-2031, ($Million)
7.3. Europe
7.3.1. Key Market Trends and Opportunities
7.3.2. Europe Bioresorbable Polymers Market Size and Forecast by Type, 2021-2031, ($Million)
7.3.3. Europe Bioresorbable Polymers Market Size and Forecast by Application, 2021-2031, ($Million)
7.3.4. Europe Bioresorbable Polymers Market Size and Forecast by Country, 2021-2031, ($Million)
7.3.5. Germany
7.3.5.1. Germany Bioresorbable Polymers Market Size and Forecast by Type, 2021-2031, ($Million)
7.3.5.2. Germany Bioresorbable Polymers Market Size and Forecast by Application, 2021-2031, ($Million)
7.3.6. France
7.3.6.1. France Bioresorbable Polymers Market Size and Forecast by Type, 2021-2031, ($Million)
7.3.6.2. France Bioresorbable Polymers Market Size and Forecast by Application, 2021-2031, ($Million)
7.3.7. U.K.
7.3.7.1. U.K. Bioresorbable Polymers Market Size and Forecast by Type, 2021-2031, ($Million)
7.3.7.2. U.K. Bioresorbable Polymers Market Size and Forecast by Application, 2021-2031, ($Million)
7.3.8. Spain
7.3.8.1. Spain Bioresorbable Polymers Market Size and Forecast by Type, 2021-2031, ($Million)
7.3.8.2. Spain Bioresorbable Polymers Market Size and Forecast by Application, 2021-2031, ($Million)
7.3.9. Italy
7.3.9.1. Italy Bioresorbable Polymers Market Size and Forecast by Type, 2021-2031, ($Million)
7.3.9.2. Italy Bioresorbable Polymers Market Size and Forecast by Application, 2021-2031, ($Million)
7.3.10. Rest of Europe
7.3.10.1. Rest of Europe Bioresorbable Polymers Market Size and Forecast by Type, 2021-2031, ($Million)
7.3.10.2. Rest of Europe Bioresorbable Polymers Market Size and Forecast by Application, 2021-2031, ($Million)
7.4. Asia-Pacific
7.4.1. Key Market Trends and Opportunities
7.4.2. Asia-Pacific Bioresorbable Polymers Market Size and Forecast by Country, 2021-2031, ($Million)
7.4.3. Asia-Pacific Bioresorbable Polymers Market Size and Forecast by Application, 2021-2031, ($Million)
7.4.4. Asia-Pacific Bioresorbable Polymers Market Size and Forecast by Type, 2021-2031, ($Million)
7.4.5. China
7.4.5.1. China Bioresorbable Polymers Market Size and Forecast by Type, 2021-2031, ($Million)
7.4.5.2. China Bioresorbable Polymers Market Size and Forecast by Application, 2021-2031, ($Million)
7.4.6. India
7.4.6.1. India Bioresorbable Polymers Market Size and Forecast by Type, 2021-2031, ($Million)
7.4.6.2. India Bioresorbable Polymers Market Size and Forecast by Application, 2021-2031, ($Million)
7.4.7. Japan
7.4.7.1. Japan Bioresorbable Polymers Market Size and Forecast by Type, 2021-2031, ($Million)
7.4.7.2. Japan Bioresorbable Polymers Market Size and Forecast by Application, 2021-2031, ($Million)
7.4.8. South Korea
7.4.8.1. South Korea Bioresorbable Polymers Market Size and Forecast by Type, 2021-2031, ($Million)
7.4.8.2. South Korea Bioresorbable Polymers Market Size and Forecast by Application, 2021-2031, ($Million)
7.4.9. Rest of APAC
7.4.9.1. Rest of APAC Bioresorbable Polymers Market Size and Forecast by Type, 2021-2031, ($Million)
7.4.9.2. Rest of APAC Bioresorbable Polymers Market Size and Forecast by Application, 2021-2031, ($Million)
7.5. Rest of the World
7.5.1. Key Market Trends and Opportunities
7.5.2. Rest of the World Bioresorbable Polymers Market Size and Forecast by Type, 2021-2031, ($Million)
7.5.3. Rest of the World Bioresorbable Polymers Market Size and Forecast by Application, 2021-2031, ($Million)
7.5.4. Rest of the World Bioresorbable Polymers Market Size and Forecast by Country, 2021-2031, ($Million)
7.5.5. Latin America
7.5.5.1. Latin America Bioresorbable Polymers Market Size and Forecast by Type, 2021-2031, ($Million)
7.5.5.2. Latin America Bioresorbable Polymers Market Size and Forecast by Application, 2021-2031, ($Million)
7.5.6. Middle East
7.5.6.1. Middle East Bioresorbable Polymers Market Size and Forecast by Type, 2021-2031, ($Million)
7.5.6.2. Middle East Bioresorbable Polymers Market Size and Forecast by Application, 2021-2031, ($Million)
7.5.7. Africa
7.5.7.1. Africa Bioresorbable Polymers Market Size and Forecast by Type, 2021-2031, ($Million)
7.5.7.2. Africa Bioresorbable Polymers Market Size and Forecast by Application, 2021-2031, ($Million)
Chapter 8. Competitive Landscape
8.1. Market Overview
8.2. Market Share Analysis/Key Player Positioning
8.3. Developmental Strategy Benchmarking
8.3.1. New Product Development
8.3.2. Product Launches
8.3.3. Business Expansions
8.3.4. Partnerships, Joint Ventures, and Collaborations
8.3.5. Mergers and Acquisitions
Chapter 9. Company Profiles
9.1. Corbion N.V.
9.1.1. Company Snapshot
9.1.2. Financial Performance
9.1.3. Product Offerings
9.1.4. Key Strategic Initiatives
9.1.5. SWOT Analysis
9.2. Evonik Industries AG
9.2.1. Company Snapshot
9.2.2. Financial Performance
9.2.3. Product offerings
9.2.4. Key Strategic Initiatives
9.2.5. SWOT Analysis
9.3. Foster Corporation
9.3.1. Company Snapshot
9.3.2. Financial Performance
9.3.3. Product offerings
9.3.4. Key Strategic Initiatives
9.3.5. SWOT Analysis
9.4. KLS Martin Group
9.4.1. Company Snapshot
9.4.2. Financial Performance
9.4.3. Product offerings
9.4.4. Key Strategic Initiatives
9.4.5. SWOT Analysis
9.5. DSM Biomedical, Inc
9.5.1. Company Snapshot
9.5.2. Financial Performance
9.5.3. Product offerings
9.5.4. Key Strategic Initiatives
9.5.5. SWOT Analysis
9.6. Ashland Global Holdings Inc.
9.6.1. Company Snapshot
9.6.2. Financial Performance
9.6.3. Product offerings
9.6.4. Key Strategic Initiatives
9.6.5. SWOT Analysis
9.7. Zeus Industrial Products, Inc
9.7.1. Company Snapshot
9.7.2. Financial Performance
9.7.3. Product offerings
9.7.4. Key Strategic Initiatives
9.7.5. SWOT Analysis
9.8. Seqens Group
9.8.1. Company Snapshot
9.8.2. Financial Performance
9.8.3. Product offerings
9.8.4. Key Strategic Initiatives
9.8.5. SWOT Analysis
9.9. REVA Medical, LLC
9.9.1. Company Snapshot
9.9.2. Financial Performance
9.9.3. Product offerings
9.9.4. Key Strategic Initiatives
9.9.5. SWOT Analysis
9.10. Poly-Med Incorporated
9.10.1. Company Snapshot
9.10.2. Financial Performance
9.10.3. Product offerings
9.10.4. Key Strategic Initiatives
9.10.5. SWOT Analysis
*The list of company is subject to change during the final compilation of the report
Key Players
Market Segments
By Type
- Polylactic acid (PLA)
- Polyglycolic acid (PGA)
- Polylactic-co-glycolic acid (PLGA)
- Polycaprolactone(PCL)
By Application
- Orthopedic devices
- Drug delivery
- Others
By Region
- North America
- The U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Rest of the World
- Latin America
- Middle East
- Africa